Bonn

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Huntington's disease1 trial

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Recruiting2 trials

Lead sponsor

• Alnylam Pharmaceuticals1 trial
• Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1 trial

Running trials

• Recruiting

  A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease

  NCT06585449· Phase 1· Alnylam Pharmaceuticals· Source

• Recruiting

  Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

  NCT04580420· Phase 2· Dicerna Pharmaceuticals, Inc., a Novo Nordisk company· Source

  Contact: Clinical Trial Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Huntington's disease1 recruiting